###begin article-title 0
###xml 90 99 <span type="species:ncbi:7955">Zebrafish</span>
Application of the dual-luciferase reporter assay to the analysis of promoter activity in Zebrafish embryos
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The dual-luciferase assay has been widely used in cell lines to determine rapidly but accurately the activity of a given promoter. Although this strategy has proved very useful, it does not allow the promoter and gene function to be analyzed in the context of the whole organism.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 204 212 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
Here, we present a rapid and sensitive assay based on the classical dual-luciferase reporter technique which can be used as a new tool to characterize the minimum promoter region of a gene as well as the in vivo response of inducible promoters to different stimuli. We illustrate the usefulness of this system for studying both constitutive (telomerase) and inducible (NF-kappaB-dependent) promoters. The flexibility of this assay is demonstrated by induction of the NF-kappaB-dependent promoters using simultaneous microinjection of different pathogen-associated molecular patterns as well as with the use of morpholino-gene mediated knockdown.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 62 71 62 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 97 112 <span type="species:ncbi:10090">transgenic mice</span>
This assay has several advantages compared with the classical in vitro (cell lines) and in vivo (transgenic mice) approaches. Among others, the assay allows a rapid and quantitative measurement of the effects of particular genes or drugs in a given promoter in the context of a whole organism and it can also be used in high throughput screening experiments.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 222 230 222 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 826 827 826 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 828 829 828 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
###xml 548 557 <span type="species:ncbi:7955">zebrafish</span>
###xml 712 721 <span type="species:ncbi:7955">zebrafish</span>
###xml 741 747 <span type="species:ncbi:9606">humans</span>
###xml 795 800 <span type="species:ncbi:9606">human</span>
The zebrafish has been established as an excellent model for studying any biological process. This organism possesses many advantages including ease of experimentation, optical clarity, drug administration, amenability to in vivo manipulation and feasibility of reverse and forward genetic approaches. The fish reach sexual maturity in only 3 to 4 months, and adult females are capable of producing 100 to 200 eggs weekly. Many thousands of animals can be kept in a fish facility requiring much less space than mice or other mammals, and hence the zebrafish is regarded as a cost-effective experimental vertebrate model for large-scale genetic screening [1]. Furthermore, the high degree of homology between the zebrafish genome and that of humans makes such discoveries especially pertinent to human disease and development [2,3].
###end p 9
###begin p 10
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 834 846 834 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Discosoma sp</italic>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 93 102 <span type="species:ncbi:7955">zebrafish</span>
###xml 310 319 <span type="species:ncbi:7955">zebrafish</span>
###xml 436 445 <span type="species:ncbi:7955">zebrafish</span>
###xml 513 522 <span type="species:ncbi:7955">zebrafish</span>
###xml 629 638 <span type="species:ncbi:7955">zebrafish</span>
Morpholino antisense oligonucleotides (MO) have been widely used to inhibit gene function in zebrafish embryos [4-7] and are usually used as sequence-specific translation-blocking or splicing-blocking agents. Recently, a quantitative assessment of the knockdown efficiency of morpholinos has been performed in zebrafish embryos and its effectiveness proved [8]. Furthermore, microinjection of DNA constructs into single-cell fertilized zebrafish embryos has also proven successful in the generation of transgenic zebrafish. The widespread use of fluorescent proteins in mammalian systems has been successfully adapted for use in zebrafish, which are well-suited to the use of fluorescence because of their optical clarity and external development. By linking a fluorescent protein such as enhanced green fluorescent protein (eGFP) or Discosoma sp. red fluorescent protein (DsRed) to a gene or promoter of interest, expression can be easily visualized in living animals [9].
###end p 10
###begin p 11
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 622 624 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 374 383 <span type="species:ncbi:7955">zebrafish</span>
###xml 683 692 <span type="species:ncbi:7955">zebrafish</span>
The dual luciferase assay has been widely used in cell lines to determine rapidly and accurately the activity of a given promoter. Although this strategy has been very useful, it does not allow analysis of the promoter and gene function in the context of the whole organism. To overcome these limitations, we have developed a protocol based on the dual luciferase system in zebrafish embryos. We illustrate the usefulness of this system for studying the promoter of telomerase, a key enzyme in the fields of cancer, stem cells and aging [10], and a NF-kappaB-dependent promoter, a master regulator of the immune response [11]. The luciferase reporter DNA plasmids were injected into zebrafish embryos at the one-cell developmental stage, together with MO or the expression constructs of interest, and the luciferase activity was determined in the time frame of MO activity (24-48 h later). In addition, the flexibility of this assay is also illustrated by activation of the NF-kappaB-dependent promoters by simultaneous microinjection of different pathogen-associated molecular patterns (PAMPs).
###end p 11
###begin p 12
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 158 167 <span type="species:ncbi:7955">zebrafish</span>
The protocol presented here provides details of how to apply the dual-luciferase assay to determining the activity of constitutive and inducible promoters in zebrafish embryos. This approach involves three steps: (1) cloning the promoter of interest in the firefly luciferase reporter construct, (2) microinjecting the embryos with this construct together with the appropriate Renilla luciferase reporter and (3) measuring the promoter activity with the dual luciferase system in whole embryo extracts.
###end p 12
###begin title 13
Results
###end title 13
###begin p 14
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 346 355 <span type="species:ncbi:7955">zebrafish</span>
The protocol presented here should result in very sensitive and accurate measurement of promoter activity and analysis of gene function in the context of the whole organism, which represents an important advantage over traditional measurement in cell lines. We first illustrated the usefulness of our protocol to analyze the promoter activity of zebrafish telomerase-reverse transcriptase (zfTERT) (Fig. 1). At 24 h post-injection (hpi), the 3 Kb fragment upstream of the zfTERT coding sequence was able to drive the expression of the firefly luciferase reporter while the 1 Kb fragment failed to significantly increased the basal expression. Therefore, the relative promoter activity of each fragment could be quantitatively determined.
###end p 14
###begin p 15
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of zfTERT promoter activity in whole zebrafish embryos</bold>
###xml 525 531 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 46 55 <span type="species:ncbi:7955">zebrafish</span>
###xml 65 74 <span type="species:ncbi:7955">Zebrafish</span>
###xml 198 201 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Analysis of zfTERT promoter activity in whole zebrafish embryos. Zebrafish one to eight-cell embryos were microinjected with plessEGFPLuc, zfpTERT(1 Kb)-EGFPLuc or zfpTERT(3 Kb)-EGFPLuc and the pRL-CMV (10:1) reporter vectors. Twenty-four hours after microinjection, the firefly and Renilla luciferase activity was measured using the Dual-Luciferase Reporter Assay System. The results are expressed as the mean +/- S.E. of normalized luciferase activity relative to plessEGFPLuc injected embryos. *p < 0.05 vs. plessEGFPLuc. daggerp < 0.05 vs. zfpTERT(1 Kb)-EGFPLuc.
###end p 15
###begin p 16
###xml 201 210 201 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 214 222 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 593 601 589 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 725 742 721 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 747 749 743 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 758 777 754 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio anguillarum </italic>
###xml 782 784 778 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 867 869 859 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 897 899 889 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 1057 1059 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1064 1066 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1124 1126 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1259 1261 1247 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 1382 1384 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1423 1425 1407 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 1571 1573 1547 1549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 1638 1640 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1696 1698 1672 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 132 135 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 303 306 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 671 674 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 725 741 <span type="species:ncbi:562">Escherichia coli</span>
###xml 758 776 <span type="species:ncbi:55601">Vibrio anguillarum</span>
###xml 987 991 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1348 1351 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1416 1419 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1592 1596 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The critical step in the protocol presented here is the correct choice of the promoter used for normalization. The cytomegalovirus (CMV) immediate-early promoter is a strong promoter used for both the in vitro and in vivo expression of proteins in signal transduction and gene therapy studies. However, CMV activity is induced by external stimuli such as endotoxin from Gram-negative bacteria (lipopolysaccharide, LPS), cytokines and phorbol esters [12]. Therefore, for the study of NF-kappaB activation, we first have studied the effects of bacterial LPS and DNA in the expression of several Renilla luciferase reporter constructs. Among the four candidates tested, the CMV promoter was strongly induced by both PAMPs, i.e. Escherichia coli LPS (EcLPS) and Vibrio anguillarum DNA (VaDNA), whereas the translation elongation factor EF1alpha promoter was inhibited by EcLPS and, to some extent, by VaDNA. In contrast, the herpes simplex virus thymidine kinase (TK) promoter and the early SV40 enhancer/promoter region showed a more constant expression (Fig. 2A and 2B) and were therefore selected for further studies. Figure 2C illustrates the profound effects of the plasmid used for normalization in the measurement of the induction of NF-kappaB. When using EcLPS, a 29 vs. 14 fold induction of NF-kappaB activity was obtained with the TK and the CMV promoters, respectively (Fig. 2C), indicating that induction of CMV by EcLPS resulted in the underestimation of the NF-kappaB activation by this PAMP. Similarly, 21 vs. 738 fold induction of NF-kappaB was observed with VaDNA when using the SV40 and the TK promoters, respectively (Fig. 2C), indicating that the inhibition of the TK promoter by VaDNA resulted in the overestimation of the NF-kappaB induced by this PAMP.
###end p 16
###begin p 17
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Optimization of the different <italic>Renilla </italic>luciferase reporter constructs</bold>
###xml 142 149 142 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, C) </bold>
###xml 159 161 159 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 165 172 165 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, C) </bold>
###xml 455 463 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 540 547 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla</italic>
###xml 70 79 <span type="species:ncbi:7955">Zebrafish</span>
###xml 213 216 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 230 234 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Optimization of the different Renilla luciferase reporter constructs. Zebrafish one to eight-cell embryos were microinjected with 30 ng EcLPS (A, C) or 6.5 ng VaDNA (B, C) and NF-kappaB::Luc together with the pRL-CMV, pRL-TK, pRL-SV40 or pRL-EF1alpha (10:1) reporter vectors. Twenty-four hours after microinjection, the firefly and Renilla luciferase activity was measured using the Dual-Luciferase Reporter Assay System. The results are presented as the Renilla luciferase activity (A, B) or as the normalized luciferase activity (firefly/Renilla) (C). Each bar represents the mean +/- S.E. of ten replicate samples and the data are representative of three independent experiments. The asterisk denotes statistically significant differences between the indicated samples.
###end p 17
###begin p 18
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 214 216 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 267 269 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 403 405 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 673 675 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 751 752 739 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
We finally validated the usefulness of this technique for studying a gene of interest by using MO-gene mediated knockdown. Figure 3 illustrates an example of the inhibition of the NF-kappaB activation triggered by VaDNA using a translation-blocking MO against MyD88 [13], an adaptor protein involved in the downstream signalling following the engagement of bacterial DNA by its cognate receptor (TLR9) [14]. The results showed that injection of the MO against MyD88 resulted in a significant inhibition (> 30%) of the NF-kappaB activation induced by bacterial DNA, while injection of a MO directed against TLR3, which is involved in the recognition of double-stranded RNA [15], failed to affect the NF-kappaB activation induced by bacterial DNA (Fig. 3).
###end p 18
###begin p 19
###xml 0 156 0 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink">An example of the usefulness of MO-gene mediated knockdown in combination with the dual-luciferase assay for the analysis of the NF-&#954;B signaling pathway</bold>
###xml 225 227 221 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 261 269 257 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 158 167 <span type="species:ncbi:7955">Zebrafish</span>
An example of the usefulness of MO-gene mediated knockdown in combination with the dual-luciferase assay for the analysis of the NF-kappaB signaling pathway. Zebrafish one to eight-cell embryos were microinjected with 6.5 ng VaDNA together with the firefly and Renilla reporter vectors as indicated in Legend to Figure 2 alone or in combination with 4 ng of the indicated morpholinos. Twenty-four hours after microinjection, activation of the NF-kappaB activation was measured using the Dual-Luciferase Reporter Assay System. The results are expressed as normalized luciferase activity relative to control embryos not injected with MOs. Each bar represents the mean +/- S.E. of ten replicate samples and the data are representative of three independent experiments. The asterisk denotes statistically significant differences between the indicated samples.
###end p 19
###begin title 20
Discussion
###end title 20
###begin p 21
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1060 1069 1060 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1222 1224 1222 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1225 1227 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 163 172 <span type="species:ncbi:7955">zebrafish</span>
###xml 242 251 <span type="species:ncbi:7955">zebrafish</span>
###xml 433 442 <span type="species:ncbi:7955">zebrafish</span>
###xml 500 509 <span type="species:ncbi:7955">zebrafish</span>
###xml 1114 1123 <span type="species:ncbi:7955">zebrafish</span>
###xml 1214 1220 <span type="species:ncbi:9606">humans</span>
###xml 1420 1429 <span type="species:ncbi:7955">zebrafish</span>
The protocol presented here provides details of how to apply the dual-luciferase assay to determining the activity of both constitutive and inducible promoters in zebrafish embryos. Beyond genetics and experimental tools, the strength of the zebrafish resides in the analysis of phenotype [1]. Perhaps no other organism (and certainly no vertebrate) is better suited to high-throughput phenotyping. The scale that can be achieved in zebrafish experiments is impressive by vertebrate standards. Early zebrafish embryos are less than 1 mm in diameter, allowing several embryos to fit easily in a single well of a 384-well plate. Whole organisms offer several advantages over cell lines for forward chemical genetic screens, providing information on tissue specificity, toxicity and accounting for bioavailability. Furthermore, cells are not transformed and are in their normal physiological milieu of cell-cell and cell-extracellular matrix interactions [16-18]. Use of the whole organism can also allow the screening of processes that are not easily replicated in vitro such as organ development. The advantages of zebrafish screening over invertebrate model organisms are their closer evolutionary relationship to humans [16-18]. Therefore, the assay described here represents a promising route to the identification and validation of novel drug targets. Analysis of the promoter of newly identified genes that underlie zebrafish disease phenotypes might lead directly to the identification of novel drug targets or genes that can correct the phenotype.
###end p 21
###begin p 22
###xml 37 47 37 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex uterus </italic>
###xml 625 633 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1239 1247 1239 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 8 17 <span type="species:ncbi:7955">zebrafish</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
Because zebrafish development occurs ex uterus and they have a large number of offspring, hundreds or thousands of embryos can be injected per day and the results of this assay can be obtained within 24-48 h, although shorter time points can also be analyzed if either the mRNA coding for the gene under study or the recombinant protein are used. Although some variation was found between replicates, these can be easily avoided by the high number of technical replicates achievable. The high-fold induction of luciferase activity, together with barely detectable levels of basal expression, makes it an ideal system for the in vivo analysis of inducible promoters. In addition, the assay can be combined with powerful MO-gene mediated knockdown or gene over-expression to rapidly determine the functions of a particular gene (1-2 days compared with months-years needed for the generation of knockout mice). Therefore, this technique appears to be suitable for studying the activity and responses of different promoters and gene functions as well as for the validation of genetic constructs. However, this technique does not provide spatial information on gene expression and, therefore, it might be useful as a complementary technique to in situ hybridization and fluorescent microscopy. To avoid this limitation, all our promoters drive the expression of a fusion of eGFP and firefly luciferase, which might allow the simultaneous determination of the expression levels and the spatial localization of the promoter under analysis.
###end p 22
###begin p 23
###xml 426 434 426 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 654 663 654 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 667 675 667 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 939 947 939 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
###xml 575 578 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1059 1063 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1094 1098 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A shortcoming of the present assay, however, is the transient expression of the constructs and, therefore, only short-term responses of promoters can be studied. For example, the adaptive immune response can not be studied with the assay since it develops after several weeks. On the other hand, we have found that normalization is absolutely required for the elimination of experimental variations. As we have found that the Renilla luciferase plasmid used for normalization can be induced by external stimuli, the choice of the normalization plasmid is critical. Thus, the CMV immediate-early promoter, which is commonly used for normalization in both in vitro and in vivo studies, is significantly induced by external stimuli such as endotoxin (LPS) and genomic DNA from bacteria, as previously reported in cell lines with LPS, cytokines and phorbol esters [12]. However, this limitation could be easily overcome using other commercial Renilla luciferase reporter vectors, such as those driven by the herpes simplex virus TK promoter (pRL-TK) or the early SV40 enhancer/promoter region (pRL-SV40).
###end p 23
###begin title 24
Conclusion
###end title 24
###begin p 25
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
We have developed a rapid and sensitive assay based on the classical dual-luciferase reporter technique which can be used as a new tool to characterize the minimum promoter region of a gene and the in vivo response of inducible promoters to different stimuli as well as in high throughput screening experiments. The flexibility of this assay is demonstrated by induction of the NF-kappaB-dependent promoters using simultaneous microinjection of different PAMPs as well as with the use of MO-gene mediated knockdown.
###end p 25
###begin title 26
Methods
###end title 26
###begin title 27
Reagents
###end title 27
###begin p 28
###xml 11 27 11 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Photinus pyralis</italic>
###xml 65 66 65 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 11 27 <span type="species:ncbi:7054">Photinus pyralis</span>
* Firefly (Photinus pyralis) luciferase reporter plasmids (Table 1).
###end p 28
###begin p 29
Reporter plasmids used in this study
###end p 29
###begin p 30
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Note</italic>
Note: pEGFPLuc has been discontinued and is no longer available from Clontech; it can be obtained from the authors on request. Full sequences and maps can be found on the Clontech and Promega websites.
###end p 30
###begin p 31
###xml 13 31 13 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla reniformis</italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 13 31 <span type="species:ncbi:6136">Renilla reniformis</span>
###xml 69 72 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 74 77 <span type="species:ncbi:9685">Cat</span>
###xml 96 99 <span type="species:ncbi:9685">Cat</span>
###xml 120 124 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 126 129 <span type="species:ncbi:9685">Cat</span>
* Sea pansy (Renilla reniformis) reporter plasmids from Promega: pRL-CMV (Cat.# E2261), pRL-TK (Cat.# E2241) and/or pRL-SV40 (Cat.# E2231) (Table 1).
###end p 31
###begin p 32
###xml 8 17 <span type="species:ncbi:7955">zebrafish</span>
* Adult zebrafish.
###end p 32
###begin p 33
###xml 46 47 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
* Egg water (60 mg/l Ocean Salt, 0.45 mM NaHCO3, 0.0375 mM CaCO3, 0.05% Methylene Blue)
###end p 33
###begin p 34
###xml 50 59 <span type="species:ncbi:7955">Zebrafish</span>
* Agarose-modified Petri dish as described in the Zebrafish book .
###end p 34
###begin p 35
* Phenol Red Solution (0.5% in PBS, Sigma-Aldrich).
###end p 35
###begin p 36
* Buffer Tango 10x (Fermentas).
###end p 36
###begin p 37
* Morpholinos 1 mM stock solution in distilled water (Gene Tools, LLC).
###end p 37
###begin p 38
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
◈ MO-Myd88: 5'-TAGCAAAACCTCTGTTATCCAGCGA-3' [13]
###end p 38
###begin p 39
◈ MO-TLR3: 5'-GTAAAAACATACCTTTAAGAGAGAG-3'
###end p 39
###begin p 40
###xml 18 35 18 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 18 34 <span type="species:ncbi:562">Escherichia coli</span>
###xml 52 55 <span type="species:ncbi:9685">Cat</span>
###xml 76 79 <span type="species:ncbi:9685">Cat</span>
* EcLPS: LPS from Escherichia coli strains 0111:B4 (Cat.# L4391) or 055:B5 (Cat.# L6529) from Sigma-Aldrich.
###end p 40
###begin p 41
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 11 18 <span type="species:ncbi:562">E. coli</span>
###xml 57 60 <span type="species:ncbi:9685">Cat</span>
* LPS from E. coli strains 0111:B4 conjugated with FITC (Cat.# F3625).
###end p 41
###begin p 42
###xml 2 4 2 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Va</italic>
###xml 43 61 43 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio anguillarum</italic>
###xml 43 61 <span type="species:ncbi:55601">Vibrio anguillarum</span>
* VaDNA: phenol-extracted genomic DNA from Vibrio anguillarum.
###end p 42
###begin p 43
###xml 50 53 <span type="species:ncbi:9685">Cat</span>
* Dual-Luciferase Reporter Assay System (Promega, Cat.# E1910).
###end p 43
###begin p 44
* Phosphate-buffered saline (PBS).
###end p 44
###begin title 45
Equipment
###end title 45
###begin p 46
* Air incubator set at 28.5degreesC (Memmert).
###end p 46
###begin p 47
* Curved-tip forceps.
###end p 47
###begin p 48
* Straight-tip forceps.
###end p 48
###begin p 49
* Puller (PC-10, Narishige).
###end p 49
###begin p 50
* Glass Capillaries with filament (GD-1, Narishige).
###end p 50
###begin p 51
* Microloader tips (0.5-10 mul, Eppendorf).
###end p 51
###begin p 52
* Microinjector (IM300, Narishige).
###end p 52
###begin p 53
* Stereomicroscope (MZ6, Leica).
###end p 53
###begin p 54
###xml 61 64 <span type="species:ncbi:9685">Cat</span>
###xml 115 118 <span type="species:ncbi:9685">Cat</span>
* Pellet pestle, disposable (Sigma-Aldrich): Cordless motor (Cat.# Z359971) and blue polypropylene (autoclavable) (Cat.# Z359947).
###end p 54
###begin p 55
* Luminometer Optocomp I (MGM Instruments).
###end p 55
###begin p 56
* Epifluorescence Lumar V12 stereomicroscope equipped with a digital camera (AxioCam MRm) (Zeiss).
###end p 56
###begin title 57
Procedure
###end title 57
###begin title 58
Microinjection
###end title 58
###begin p 59
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1- </bold>
###xml 90 98 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
1- Prepare the microinjection mix containing 20 ng/mul of firefly luciferase and 2 ng/mul Renilla reporter plasmids. Add Buffer Tango 10x to a final concentration of 0.5x, and phenol red solution to a final concentration of 0.05%. When injecting morpholinos, they should be prepared to a final concentration of 1-10 muM.
###end p 59
###begin p 60
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CAUTION! </bold>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
CAUTION! When microinjecting exogenous molecules, such as PAMPs or drugs, check different Renilla reporter plasmids and select those with consistent expression.
###end p 60
###begin p 61
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2- </bold>
2- Immediately after spawning, collect fertilized egg with a Pasteur pipette and place them in egg water on an agarose-modified Petri dish be means of the forceps.
###end p 61
###begin p 62
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CRITICAL STEP </bold>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 54 63 <span type="species:ncbi:7955">zebrafish</span>
CRITICAL STEP It is very important to microinject the zebrafish embryos at early developmental stages (from one- to eight-cells) to ensure that the cytoplasmic flows introduce DNA into the cell (Fig. 4)
###end p 62
###begin p 63
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Molecules microinjected in the yolk sac are rapidly delivered into the embryo</bold>
###xml 79 83 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 163 167 163 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 198 200 198 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ec</italic>
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 145 154 <span type="species:ncbi:7955">zebrafish</span>
###xml 291 298 <span type="species:ncbi:562">E. coli</span>
Molecules microinjected in the yolk sac are rapidly delivered into the embryo. (A) Schematic representation of the site of injection in one-cell zebrafish embryo. (B) Visualization of FITC labelled EcLPS upon microinjection into the yolk sac. Embryos were microinjected with 3.5 ng LPS from E. coli strains 0111:B4 conjugated with FITC and examined at the indicated times with a LUMAR stereomicroscope. hpi, hours post-injection.
###end p 63
###begin p 64
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3- </bold>
3- Load glass capillaries with 1-5 mul of microinjection mix by using a 0.5-10-mul microloader tip.
###end p 64
###begin p 65
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4- </bold>
4- Put the Petri dish with the fertilized eggs under a stereomicroscope at 40x magnifications and place the loaded needle toward the yolk sac, close to the embryo cell. By using the microinjector, insert the tip of the needle into the yolk and inject a 4 nl drop by setting the proper pressure (50-60 Psi) and time (10-100 ms).
###end p 65
###begin p 66
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5- </bold>
5- Incubate the injected embryos for 24-48 h at 28.5degreesC in egg water.
###end p 66
###begin title 67
Quantitative evaluation of the response with the Dual-Luciferase Reporter Assay System
###end title 67
###begin p 68
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6- </bold>
6- The next day, collect live injected embryos and put three of them in a 1.5 ml microcentrifuge tube.
###end p 68
###begin p 69
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7- </bold>
7- Remove the egg water, wash the embryos with PBS and remove it completely.
###end p 69
###begin p 70
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CAUTION! </bold>
CAUTION! Take care during the wash because the eggs may break.
###end p 70
###begin p 71
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">8- </bold>
8- Incubate the embryos with 50 mul of passive lysis buffer (PLB) 1x for 30 min at room temperature, shaking at 150 rpm.
###end p 71
###begin p 72
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">9- </bold>
9- After incubation, homogenize the embryos with the pellet pestle.
###end p 72
###begin p 73
###xml 0 14 0 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CRITICAL STEP </bold>
CRITICAL STEP From this point onwards, protect samples from light.
###end p 73
###begin p 74
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink">10- </bold>
10- Spin the embryo extracts for 3 min at 13,000 rpm to remove cellular debris.
###end p 74
###begin p 75
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink">11- </bold>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
11- Measure firefly and Renilla luciferase activities according to the manufacturer.
###end p 75
###begin p 76
###xml 2 8 2 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Timing</bold>
* Timing
###end p 76
###begin p 77
* Step 1: 30 min. Preparation of microinjection mix.
###end p 77
###begin p 78
###xml 51 60 <span type="species:ncbi:7955">zebrafish</span>
* Step 2: 10 min. Preparation for injection of 100 zebrafish embryos.
###end p 78
###begin p 79
###xml 43 52 <span type="species:ncbi:7955">zebrafish</span>
* Steps 3-5: 15 min. Microinjection of 100 zebrafish embryos.
###end p 79
###begin p 80
###xml 66 75 <span type="species:ncbi:7955">zebrafish</span>
* Steps 6-11: 2 h. Quantitative evaluation of the response of 100 zebrafish embryos with the Dual-Luciferase Reporter Assay System.
###end p 80
###begin title 81
Authors' contributions
###end title 81
###begin p 82
F.A-P., M.L.C and V.M. designed the research, analyzed the data and wrote the paper; F.A-P. performed the research. All authors read and approved the final manuscript.
###end p 82
###begin title 83
Acknowledgements
###end title 83
###begin p 84
We thank E.M. Garcia-Navarro for excellent technical assistance and Dr. R Hay for the NF-kappaB::Luc reporter construct. This work was supported by the Spanish Ministry of Education and Science (grant BIO2005-05078 to V.M.), the Spanish Ministry of Health (grant PI060369 to M.L.C.) and the University of Murcia (fellowships to F.A.-P.)
###end p 84
###begin article-title 85
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
The art and design of genetic screens: zebrafish
###end article-title 85
###begin article-title 86
###xml 4 13 <span type="species:ncbi:7955">zebrafish</span>
The zebrafish/tumor xenograft angiogenesis assay
###end article-title 86
###begin article-title 87
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish as a powerful vertebrate model system for in vivo studies of cell death
###end article-title 87
###begin article-title 88
###xml 29 38 <span type="species:ncbi:7955">zebrafish</span>
Nonconventional antisense in zebrafish for functional genomics applications
###end article-title 88
###begin article-title 89
Morphant technology in novel developmental systems
###end article-title 89
###begin article-title 90
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
Effective targeted gene "knockdown" in zebrafish
###end article-title 90
###begin article-title 91
###xml 50 59 <span type="species:ncbi:7955">zebrafish</span>
Morpholino phosphorodiamidate oligonucleotides in zebrafish: a recipe for functional genomics?
###end article-title 91
###begin article-title 92
###xml 92 101 <span type="species:ncbi:7955">zebrafish</span>
Quantitative assessment of knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay
###end article-title 92
###begin article-title 93
###xml 24 33 <span type="species:ncbi:7955">zebrafish</span>
Fluorescent proteins in zebrafish cell and developmental biology
###end article-title 93
###begin article-title 94
Telomere length, stem cells and aging
###end article-title 94
###begin article-title 95
Signaling to NF-kappaB by Toll-like receptors
###end article-title 95
###begin article-title 96
###xml 85 88 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Analysis of signal transduction pathways in macrofages using expression vectors with CMV promoters: a cautionary tale
###end article-title 96
###begin article-title 97
###xml 34 43 <span type="species:ncbi:7955">zebrafish</span>
MyD88 innate immune function in a zebrafish embryo infection model
###end article-title 97
###begin article-title 98
The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling
###end article-title 98
###begin article-title 99
Sensing of viral infection and activation of innate immunity by toll-like receptor 3
###end article-title 99
###begin article-title 100
###xml 30 39 <span type="species:ncbi:7955">zebrafish</span>
In vivo drug discovery in the zebrafish
###end article-title 100
###begin article-title 101
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish: a new model on the pharmaceutical catwalk
###end article-title 101
###begin article-title 102
###xml 32 41 <span type="species:ncbi:7955">zebrafish</span>
Small molecule screening in the zebrafish
###end article-title 102
###begin article-title 103
###xml 66 94 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes
###end article-title 103

